- Report
- August 2026
- 144 Pages
Global
From €5243EUR$5,850USD£4,498GBP
- Report
- August 2026
- 114 Pages
Global
From €5243EUR$5,850USD£4,498GBP
- Report
- August 2026
- 183 Pages
Global
From €5243EUR$5,850USD£4,498GBP
- Report
- August 2026
- 546 Pages
Global
From €5243EUR$5,850USD£4,498GBP
- Report
- August 2026
- 243 Pages
Global
From €5243EUR$5,850USD£4,498GBP
- Report
- August 2026
- 174 Pages
Global
From €5243EUR$5,850USD£4,498GBP
- Report
- August 2026
- 484 Pages
Global
From €5243EUR$5,850USD£4,498GBP
- Report
- August 2026
- 512 Pages
Global
From €5243EUR$5,850USD£4,498GBP
- Report
- August 2026
- 154 Pages
Global
From €5243EUR$5,850USD£4,498GBP
- Report
- August 2026
- 569 Pages
Global
From €5243EUR$5,850USD£4,498GBP
- Report
- August 2026
- 183 Pages
Global
From €5243EUR$5,850USD£4,498GBP
- Report
- August 2026
- 215 Pages
Global
From €5243EUR$5,850USD£4,498GBP
- Report
- January 2026
- 110 Pages
Global
From €4257EUR$4,750USD£3,652GBP
- Report
- May 2026
- 180 Pages
Global
From €4257EUR$4,750USD£3,652GBP
- Report
- January 2026
- 280 Pages
Global
From €2689EUR$3,000USD£2,307GBP
- Report
- February 2026
- 150 Pages
Global
From €3361EUR$3,750USD£2,883GBP
- Report
- January 2026
- 280 Pages
Global
From €2689EUR$3,000USD£2,307GBP
- Report
- November 2025
- 150 Pages
Global
From €3361EUR$3,750USD£2,883GBP
- Report
- November 2025
- 150 Pages
Global
From €3361EUR$3,750USD£2,883GBP
- Report
- April 2026
- 149 Pages
Global
From €2688EUR$2,999USD£2,306GBP
€3584EUR$3,999USD£3,075GBP

Macular Degeneration is a condition that affects the central part of the retina, known as the macula, which is responsible for sharp, central vision. It is the leading cause of vision loss in people over the age of 50. Optical treatments for Macular Degeneration include laser photocoagulation, photodynamic therapy, and anti-VEGF injections. Laser photocoagulation is used to reduce the risk of further vision loss by sealing off leaking blood vessels in the macula. Photodynamic therapy is used to reduce the growth of abnormal blood vessels in the macula. Anti-VEGF injections are used to reduce the growth of abnormal blood vessels and improve vision.
Companies in the Macular Degeneration market include Novartis, Regeneron, Allergan, Genentech, and Roche. Show Less Read more